Hypersomnia’s and Neurologic Sleep Disorders

These practice parameters pertain to the treatment of hypersomnia’s of central origin. It serves as both an update of previous practice parameters for the therapy of narcolepsy and as the first practice parameters to address treatment of other hypersomnia of central origin. Specific disorders addressed by these parameters are narcolepsy (with or without cataplexy, due to medical condition), the idiopathic hypersomnia, recurrent hypersomnia and hyperxsomnia due to medical condition. Central hypersomnias are diseases manifested in excessive daytime sleepiness (EDS) not caused by disturbed nocturnal sleep or misaligned circadian rhythms. The Central hypersomnias includes narcolepsy with or without cataplexy, idiopathic hypersomnia. recurrent hypersomnia, with and without long sleep , behaviorally induced insufficient sleep disorder, Narcolepsy and hypersomnia due to medical conditions, and finally hypersomnia induced by substance intake. Epworth Sleepiness Scale is a subjective tool mostly used for Excessive daytime sleepiness assessment, Whereas the Multiple Sleep Latency Test serves as an objective diagnostic method for narcolepsy and idiopathic hypersomnias. As for symptomatic therapy of EDS, the central nervous system stimulants modafinil and methylphenidate seem to work well in most cases and in narcolepsy and Parkinson’s disease; sodium oxybate also has notable therapeutic value. In 1966, William Dement proposed that patients with excessive daytime sleepiness, but without cataplexy, sleep paralysis, or sleep-onset rapid eye movement (REM), should not be considered narcoleptic. In 1972, Roth described a type of hypersomnia with sleep drunkenness that consists of difficulty coming to complete wakefulness, confusion, disorientation, poor motor coordination, and slowness, accompanied by deep and prolonged sleep. The abrupt sleep attacks seen in classic narcolepsy are not present in this disorder.

  • Primary hypersomnias : origin and causes
  • Primary hypersomnia mimics and genetic roots
  • Secondary hypersomnias as underlying symptoms of other disorders

Related Conference of Hypersomnia’s and Neurologic Sleep Disorders

October 12-14, 2017

24th International Conference on Psychiatry & Psychosomatic Medicine

Park Inn by Radisson, London, UK
October 16-17, 2017

17th Global Neuroscience Conference

Osaka, Japan
November 20-21, 2017

28th International Conference on Psychiatry & Mental Health

Melbourne, Australia
February 22-23, 2018

10th International Conference on Vascular Dementia

Paris, France
June 14-16, 2018

25th World Congress on Neurology & Neuroscience

Amsterdam, Netherlands

November 5-6, 2018

World Summit on Spine and Spinal Disorders

San Franciso, USA
July 16-17, 2018

25th World Congress on Neurology and Neurodisorders

Melbourne, Australia
August 06-08, 2018

26th European Neurology Congress

Madrid, Spain
September 17-18, 2018

International Conference on Nervous System and Nerve Diseases

Philadelphia , USA
August 29-30, 2018

4th World Congress on Parkinsons & Huntington Disease

Zurich, Switzerland
August 29-30, 2018

4th International Conference on Epilepsy & Treatment

Zurich, Switzerland
September 13-14, 2018

7th International Conference on Neurological Disorders & Stroke

Prague, Czech Republic
September 13-14, 2018

4th International Conference on Spine and Spinal Disorders

Prague, Czech Republic
September 17-18, 2018

4th World Congress on Epilepsy and Treatment

Bali, Indonesia
November 5-6, 2018

5th International Conference on Spine and Spinal Disorders

San Franciso, USA

Hypersomnia’s and Neurologic Sleep Disorders Conference Speakers

Recommended Sessions

Related Journals

Are you interested in